TATAA Biocenter Expands Its Next-Generation Sequencing Offerings with HTG Molecular Diagnostics’ Unique HTG EdgeSeq System
HTG Molecular Diagnostics Fulfills First Orders for its Next-Generation Sequencing-Based HTG EdgeSeq Precision Immuno-Oncology Panel
HTG Molecular Diagnostics and Oncologie Complete Master Agreement to Partner on Biomarker Development for Immuno-oncology Drug Development
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
medical-device-investing HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock
HTG Molecular Diagnostics Announces Distribution Agreements with Gamidor in Israel and Durviz in Spain and Portugal
